Search research articles
Contact Us
Filters
Showing results (51-60 of 488) with videos related to
Page
of 49
Sort By:
Pharmacogenetics and Genomics
|
February 15, 2013
MTHFR polymorphisms and capecitabine-induced toxicity in patients with metastatic colorectal cancer
Lieke H van Huis-Tanja, Hans Gelderblom, Cornelis J A Punt, et al.
Future Oncology (London, England)
|
September 17, 2024
MANEUVER: A Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patients
Xiaohui Niu, Vinod Ravi, Boyao Shan, et al.
Cancers
|
August 29, 2024
Machine Learning versus Cox Models for Predicting Overall Survival in Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data
Marta Spreafico, Audinga-Dea Hazewinkel, Michiel A J van de Sande, et al.
Plos One
|
December 18, 2018
Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
Jara Baas, Lisanne Krens, Stefan Bohringer, et al.
Pharmacogenomics
|
July 7, 2010
Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle
Jan Pander, Judith A M Wessels, Ron H J Mathijssen, et al.
The Oncologist
|
November 6, 2008
False-positive serum human chorionic gonadotropin (HCG) in a male patient with a malignant germ cell tumor of the testis: a case report and review of the literature
Bart E P B Ballieux, Nir I Weijl, Hans Gelderblom, et al.
Cancers
|
April 30, 2021
Treatment Strategies for Metastatic Soft Tissue Sarcomas
Lisette M Wiltink, Rick L M Haas, Hans Gelderblom, et al.
Drug Discovery Today
|
September 24, 2014
Individualized dosing of tyrosine kinase inhibitors: are we there yet?
Djoeke de Wit, Henk-Jan Guchelaar, Jan den Hartigh, et al.
Pharmacogenomics
|
May 17, 2016
Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patients
Carin Atc Lunenburg, Maurice C van Staveren, Hans Gelderblom, et al.
Cancers
|
April 27, 2024
Bevacizumab Treatment for Patients with <i>NF2</i>-Related Schwannomatosis: A Single Center Experience
Jules P J Douwes, Erik F Hensen, Jeroen C Jansen, et al.
Page
of 49
Search research articles
Search
Showing results (51-60 of 488) with videos related to
Sort By:
Page
of 49
Pharmacogenetics and Genomics
|
February 15, 2013
MTHFR polymorphisms and capecitabine-induced toxicity in patients with metastatic colorectal cancer
Lieke H van Huis-Tanja, Hans Gelderblom, Cornelis J A Punt, et al.
Future Oncology (London, England)
|
September 17, 2024
MANEUVER: A Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patients
Xiaohui Niu, Vinod Ravi, Boyao Shan, et al.
Cancers
|
August 29, 2024
Machine Learning versus Cox Models for Predicting Overall Survival in Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data
Marta Spreafico, Audinga-Dea Hazewinkel, Michiel A J van de Sande, et al.
Plos One
|
December 18, 2018
Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
Jara Baas, Lisanne Krens, Stefan Bohringer, et al.
Pharmacogenomics
|
July 7, 2010
Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle
Jan Pander, Judith A M Wessels, Ron H J Mathijssen, et al.
The Oncologist
|
November 6, 2008
False-positive serum human chorionic gonadotropin (HCG) in a male patient with a malignant germ cell tumor of the testis: a case report and review of the literature
Bart E P B Ballieux, Nir I Weijl, Hans Gelderblom, et al.
Cancers
|
April 30, 2021
Treatment Strategies for Metastatic Soft Tissue Sarcomas
Lisette M Wiltink, Rick L M Haas, Hans Gelderblom, et al.
Drug Discovery Today
|
September 24, 2014
Individualized dosing of tyrosine kinase inhibitors: are we there yet?
Djoeke de Wit, Henk-Jan Guchelaar, Jan den Hartigh, et al.
Pharmacogenomics
|
May 17, 2016
Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patients
Carin Atc Lunenburg, Maurice C van Staveren, Hans Gelderblom, et al.
Cancers
|
April 27, 2024
Bevacizumab Treatment for Patients with <i>NF2</i>-Related Schwannomatosis: A Single Center Experience
Jules P J Douwes, Erik F Hensen, Jeroen C Jansen, et al.
Page
of 49